Basel Medical Group Ltd (BMGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 06-2024 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 1,045 | 2,342 | 5,450 | 1,440 |
| Receivables | 9,661 | 7,651 | 3,676 | 9,270 |
| Inventories | 259 | 296 | 73 | 53 |
| Other current assets | 25 | 25 | 1,383 | 1,171 |
| TOTAL | $10,989 | $10,314 | $10,582 | $11,934 |
| Non-Current Assets | ||||
| PPE Net | 250 | 2,448 | 776 | 769 |
| Other Non-Current Assets | 4,375 | 222 | 56 | 57 |
| TOTAL | $4,625 | $2,670 | $833 | $826 |
| Total Assets | $15,615 | $13,252 | $10,931 | $12,034 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 2,290 | 1,668 | 3,200 | 1,997 |
| Accounts payable and accrued liabilities | 3,548 | 5,435 | 1,500 | 1,901 |
| Other current liabilities | 12 | 1,303 | 916 | 1,388 |
| TOTAL | $5,850 | $8,406 | $5,615 | $5,286 |
| Non-Current Liabilities | ||||
| Long Term Debt | 4,697 | 1,021 | N/A | 1,168 |
| TOTAL | $4,727 | $1,021 | $N/A | $1,168 |
| Total Liabilities | $10,576 | $9,427 | $5,615 | $6,454 |
| Shareholders' Equity | ||||
| Common Shares | 25,609 | 25,609 | 17,900 | 18,363 |
| Other shareholders' equity | -20,571 | -21,784 | -12,585 | -12,783 |
| TOTAL | $5,038 | $3,825 | $5,315 | $5,580 |
| Total Liabilities And Equity | $15,615 | $13,252 | $10,931 | $12,034 |